{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06307431",
            "orgStudyIdInfo": {
                "id": "V940-004"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-505177-32",
                    "type": "OTHER",
                    "domain": "EU CT"
                }
            ],
            "organization": {
                "fullName": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004)",
            "officialTitle": "A Phase 2, Randomized, Double-blind, Clinical Study of V940 (mRNA-4157) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in the Adjuvant Treatment of Participants With Renal Cell Carcinoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-adjuvant-and-pembrolizumab-in-renal-cell-carcinoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-01-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2032-06-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-06",
            "studyFirstSubmitQcDate": "2024-03-06",
            "studyFirstPostDateStruct": {
                "date": "2024-03-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "ModernaTX, Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of the study is to compare V940 plus pembrolizumab to placebo plus pembrolizumab with respect to disease-free survival (DFS) as assessed by the investigator. The primary hypothesis is that V940 plus pembrolizumab is superior to placebo plus pembrolizumab with respect to DFS."
        },
        "conditionsModule": {
            "conditions": [
                "Renal Cell Carcinoma"
            ],
            "keywords": [
                "Programmed Cell Death-1 (PD1, PD-1)",
                "Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)",
                "Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 272,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "V940 + Pembrolizumab",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive V940 1 mg via intramuscular (IM) injection every 3 weeks (Q3W) for up to 9 doses plus Pembrolizumab 400 mg via an intravenous (IV) infusion every 6 weeks (Q6W) for 9 cycles (up to \\~54 weeks). Each cycle is 6 weeks.",
                    "interventionNames": [
                        "Biological: V940",
                        "Biological: Pembrolizumab"
                    ]
                },
                {
                    "label": "Placebo + Pembrolizumab",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive placebo as an IM injection Q3W for up to 9 doses plus Pembrolizumab 400 mg via an IV infusion Q6W for 9 cycles (up to \\~54 weeks). Each cycle is 6 weeks.",
                    "interventionNames": [
                        "Biological: Pembrolizumab",
                        "Biological: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "V940",
                    "description": "IM injection",
                    "armGroupLabels": [
                        "V940 + Pembrolizumab"
                    ],
                    "otherNames": [
                        "mRNA-4157"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Pembrolizumab",
                    "description": "IV infusion",
                    "armGroupLabels": [
                        "Placebo + Pembrolizumab",
                        "V940 + Pembrolizumab"
                    ],
                    "otherNames": [
                        "MK-3475",
                        "KEYTRUDA\u00ae"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Placebo",
                    "description": "IM injection",
                    "armGroupLabels": [
                        "Placebo + Pembrolizumab"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Disease-Free Survival (DFS)",
                    "description": "DFS, as assessed by the investigator, is defined as the time from randomization to the first documented local recurrence, or occurrence of distant kidney cancer metastasis(es), or death due to any cause, whichever occurs first.",
                    "timeFrame": "up to ~43 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Overall Survival (OS)",
                    "description": "OS is defined as the time from randomization to death due to any cause.",
                    "timeFrame": "up to ~96 months"
                },
                {
                    "measure": "Distant Metastasis-free survival (DMFS)",
                    "description": "DMFS is defined as the time from randomization to the first diagnosis of a distant metastasis, or death due to any cause, whichever occurs first. Distant metastasis refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.",
                    "timeFrame": "up to ~ 43 months"
                },
                {
                    "measure": "Percentage of Participants Who Experience an Adverse Event (AE)",
                    "description": "An AE is defined as any unfavorable and unintended sign, symptom, disease, or worsening of preexisting condition temporally associated with study treatment and irrespective of causality to study treatment. The percentage of participants that experience at least one AE will be reported.",
                    "timeFrame": "up to ~15 months"
                },
                {
                    "measure": "Percentage of Participants Who Discontinue Study Treatment Due to an AE",
                    "description": "An AE is defined as any unfavorable and unintended sign, symptom, disease, or worsening of preexisting condition temporally associated with study treatment and irrespective of causality to study treatment. The percentage of participants who discontinue study treatment due to an AE will be reported.",
                    "timeFrame": "up to ~12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Has histologically or cytologically confirmed diagnosis of renal cell carcinoma (RCC) with clear cell or papillary histology.\n* Has intermediate-high-risk, high-risk, or M1 no evidence of disease (NED) RCC as defined by the following pathological tumor-node metastasis and tumor grading:\n* Intermediate-high-risk RCC: pT2 Gr4, N0, M0; pT3 Gr3/4, N0, M0\n* High-risk RCC: pT4, N0, M0; pT any stage, N1, M0\n* M1 NED RCC participants who present not only with the primary kidney tumor, but also solid, isolated, soft tissue metastases that can be completely resected at 1 of the following: the time of nephrectomy (synchronous), or \u22642 years from nephrectomy (metachronous)\n* Has undergone complete resection of the primary tumor (partial or radical nephrectomy) and complete resection of solid, isolated, soft tissue metastatic lesion(s) in M1 NED participants.\n* Must have undergone a nephrectomy and/or metastasectomy \u226412 weeks prior to randomization and recovered from surgery and any post-operative complications before randomization.\n* Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 7 days before randomization.\n\nExclusion Criteria:\n\n* Has had a major surgery other than nephrectomy plus resection of preexisting metastases for M1 NED participants, within 4 weeks prior to randomization.\n* Has residual thrombus post nephrectomy in the vena renalis or vena cava.\n* Received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization.\n* Received prior radiotherapy within 2 weeks of start of study intervention, or radiation-related toxicities, requiring corticosteroids.\n* Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention. Administration of killed vaccines is allowed.\n* Received prior treatment with a cancer vaccine.\n* Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy.\n* Has a known additional malignancy that is progressing or has required active treatment within the past 3 years.\n* Has a history of brain or bone metastatic lesions.\n* Has severe hypersensitivity to study medication or any of the substances used to prepare the study medication.\n* Has an active autoimmune disease that has required systemic treatment in the past 2 years.\n* Has a history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease.\n* Has an active infection requiring systemic therapy.\n* History of allogeneic tissue/solid organ transplant.\n* Has not adequately recovered from major surgery or has ongoing surgical complications.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Toll Free Number",
                    "role": "CONTACT",
                    "phone": "1-888-577-8839",
                    "email": "Trialsites@merck.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Merck Sharp & Dohme LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope Comprehensive Cancer Center-Medical Oncology ( Site 0104)",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "626-375-6004"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Yale-New Haven Hospital-Yale Cancer Center ( Site 0102)",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06510",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "203-785-5720"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Dana-Farber Cancer Institute-GU ( Site 0101)",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "617-632-5456"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center ( Site 0100)",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "646-422-4312"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Abramson Cancer Center ( Site 0107)",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "215-662-7046"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Fox Chase Cancer Center ( Site 0111)",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19111",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "215-728-3889"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Hospital Brit\u00e1nico de Buenos Aires-Oncology ( Site 1106)",
                    "status": "RECRUITING",
                    "city": "Ciudad aut\u00f3noma de Buenos Aires",
                    "state": "Buenos Aires",
                    "zip": "C1280AEB",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "54911563819972"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Instituto Alexander Fleming-Alexander Fleming ( Site 1101)",
                    "status": "RECRUITING",
                    "city": "Ciudad Aut\u00f3noma de Buenos Aires",
                    "state": "Caba",
                    "zip": "1426",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "5491149455892"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Fundacion Estudios Clinicos ( Site 1104)",
                    "status": "RECRUITING",
                    "city": "Rosario",
                    "state": "Santa Fe",
                    "zip": "S2000CEJ",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+5493585628491"
                        }
                    ],
                    "geoPoint": {
                        "lat": -32.94682,
                        "lon": -60.63932
                    }
                },
                {
                    "facility": "Fundacion Estudios Clinicos ( Site 1111)",
                    "status": "RECRUITING",
                    "city": "Rosario",
                    "state": "Santa Fe",
                    "zip": "S2000CEJ",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+5493469699922"
                        }
                    ],
                    "geoPoint": {
                        "lat": -32.94682,
                        "lon": -60.63932
                    }
                },
                {
                    "facility": "Macquarie University-MQ Health Clinical Trials Unit ( Site 1502)",
                    "status": "RECRUITING",
                    "city": "Macquarie University",
                    "state": "New South Wales",
                    "zip": "2109",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+61 2 9812 3526"
                        }
                    ]
                },
                {
                    "facility": "Westmead Hospital-Department of Medical Oncology ( Site 1501)",
                    "status": "RECRUITING",
                    "city": "Westmead",
                    "state": "New South Wales",
                    "zip": "2145",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "61411462609"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.80383,
                        "lon": 150.98768
                    }
                },
                {
                    "facility": "Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si",
                    "status": "RECRUITING",
                    "city": "Brisbane",
                    "state": "Queensland",
                    "zip": "4029",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "61402240196"
                        }
                    ],
                    "geoPoint": {
                        "lat": -27.46794,
                        "lon": 153.02809
                    }
                },
                {
                    "facility": "Fiona Stanley Hospital-Medical Oncology ( Site 1503)",
                    "status": "RECRUITING",
                    "city": "Murdoch",
                    "state": "Western Australia",
                    "zip": "6150",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "61861520954"
                        }
                    ],
                    "geoPoint": {
                        "lat": -32.06987,
                        "lon": 115.83757
                    }
                },
                {
                    "facility": "BC Cancer Vancouver ( Site 0005)",
                    "status": "RECRUITING",
                    "city": "Vancouver",
                    "state": "British Columbia",
                    "zip": "V5Z 4E6",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "6048776000"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.24966,
                        "lon": -123.11934
                    }
                },
                {
                    "facility": "CHU de Quebec - Universit\u00e9 Laval - Hotel Dieu de Quebec ( Site 0008)",
                    "status": "RECRUITING",
                    "city": "Qu\u00e9bec",
                    "state": "Quebec",
                    "zip": "G1R 2J6",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "4185254444"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                },
                {
                    "facility": "FALP-UIDO ( Site 1202)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "7500921",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "56224457254"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Pontificia Universidad Catolica de Chile-Centro del C\u00e1ncer ( Site 1205)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "8330032",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "56223547919"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Bradfordhill-Clinical Area ( Site 1201)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "8420383",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56954240753"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "ONCOCENTRO APYS-ACEREY ( Site 1200)",
                    "status": "RECRUITING",
                    "city": "Vi\u00f1a del Mar",
                    "state": "Valparaiso",
                    "zip": "2520598",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56992369820"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.02457,
                        "lon": -71.55183
                    }
                },
                {
                    "facility": "Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 1701)",
                    "status": "RECRUITING",
                    "city": "Kaohsiung Niao Sung Dist",
                    "state": "Kaohsiung",
                    "zip": "83301",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+886773171233267"
                        }
                    ]
                },
                {
                    "facility": "China Medical University Hospital-Department of Urology ( Site 1702)",
                    "status": "RECRUITING",
                    "city": "Taichung",
                    "zip": "40447",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "886-975-681295"
                        }
                    ],
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "Taipei Veterans General Hospital ( Site 1703)",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "112",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "886228757519"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Addenbrooke's Hospital ( Site 1004)",
                    "status": "RECRUITING",
                    "city": "Cambridge",
                    "state": "Cambridgeshire",
                    "zip": "CB2 2QQ",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "44 (0) 1223 274401"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.2,
                        "lon": 0.11667
                    }
                },
                {
                    "facility": "St Bartholomew's Hospital ( Site 1000)",
                    "status": "RECRUITING",
                    "city": "London",
                    "state": "London, City Of",
                    "zip": "EC1A 7BE",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "020 7822 8498"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Merck Clinical Trials Information",
                    "url": "http://www.merckclinicaltrials.com"
                },
                {
                    "label": "Plain Language Summary",
                    "url": "https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=V940-004&&kw=V940-004"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf",
            "url": "http://engagezone.msd.com/ds_documentation.php"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000002292",
                    "term": "Carcinoma, Renal Cell"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000007680",
                    "term": "Kidney Neoplasms"
                },
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6845",
                    "name": "Death",
                    "relevance": "LOW"
                },
                {
                    "id": "M5548",
                    "name": "Carcinoma, Renal Cell",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M10703",
                    "name": "Kidney Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4906",
                    "name": "Renal Cell Carcinoma",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1341",
                    "name": "Clear Cell Renal Cell Carcinoma",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}